Robert Stephen Bednarek

Robert Bednarek practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Robert Bednarek's NPI, 1902291875, was assigned on March 30, 2015. Robert Bednarek holds Indiana license 01083583A.

Robert Bednarek's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Robert Bednarek's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. The medical group on file is Parkview Physicians Group. Dmand AI also links Robert Bednarek to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Robert Bednarek practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Robert Bednarek's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Robert Bednarek's licenses on file in 2 states: Indiana and Missouri.

CMS data shows 1,001 Medicare services from Robert Bednarek across 19 procedure codes in 2024, for 357 Medicare patients. Medicare paid $290,586 for them. Every service was in an office.

CMS counts 357 Medicare patients who saw Robert Bednarek in 2024. The largest group is 75 to 84, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Robert Bednarek's median patient age at 78, with 44% women.

In 2024, Robert Bednarek wrote 690 Medicare Part D claims for 504 patients. 99% of them were for generic drugs. CMS names the drug for 637 of them, across 5 drugs with 11 or more claims each, at $6,050 in total drug cost. In 2023, CMS named 510 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Robert Bednarek for performance year 2024, reported as part of a group. Robert Bednarek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 140 procedures of melanoma (skin cancer) excision by Robert Bednarek, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Robert Bednarek, published from 2016 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential, Hand Dermatoses and Mohs Surgery. Robert Bednarek's most frequent co-authors are Ashish Arshanapalli, Navid Ezra, MD and Nicholas Joseph Golda, MD.

CMS Open Payments shows 116 general payments to Robert Bednarek from 20 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $565.